Lyumjev vs. Fiasp.
Hi. Has anyone switched from Fiasp (fast acting aspart.) to Lyumjev (fast acting lispro)? I am contemplating a change, but my doc seems unenthusiastic about the idea. I have seen one study that found measurable benefits to Lyumjev (speed, effectiveness, etc.). Albeit the study was funded by the manufacturer of the drug.
I am a 68 year-old man, and I was diagnosed 50 years ago. I have not seen much on this site regarding Lyumjev. Any experiences with Lyumjev in the group? Thanks.
Laurence
Interested in more discussions like this? Go to the Diabetes & Endocrine System Support Group.
@hishamganz I resent it when I have to choose healthcare treatments based on what my insurance will allow (instead of what my provider recommends). Then again the insurance holds the purse strings. I have experienced this type of thing several times. My provider has been very understanding of insurance requirements and has been helpful to find solutions that provide the best healthcare for me without upsetting insurance. A couple of times this has meant submitting documentation about why a particular treatment is necessary and explaining that the insurance authorized product is unacceptable. Could you ask your provider for this kind of support?
Thank you so much for your valuable info. I have sent it to my health care provider to start the journey with my insurance. Another thank you for the book you recommended. I read 39 pages of it in two days. I took valuable notes out of it.